W. French Anderson, "Genetics and Human Malleability,"
Hastings Center Report, 20:1 (January/February, 1990) 23.
W. French Anderson, in a more recent work with John C. Fletcher,
argues that the situation is changing. Whereas in the 1970s and
1980s there was a strong taboo against germline modification,
in the 1990s that taboo is lifting. "Searches for cure and
prevention of genetic disorders by germ-line therapy arise from
principles of beneficence and non-maleficence, which create imperatives
to relieve and prevent basic causes of human suffering. It follows
from this ethical imperative that society ought not to draw a
moral line between intentional germ-line therapy and somatic cell
therapy. "Germ-Line Gene Therapy: A New Stage of Debate,"
Law, Medicine, and Health Care, 20:1/2 (Spring/Summer,
To return to the previous topic,
click on your browser's 'Back' button.